News | April 20, 2026
Eli Lilly flags counterfeit Mounjaro seizure in Gurugram
The company said it is supporting the ongoing investigation and reiterated its commitment to patient safety.
The company said it is supporting the ongoing investigation and reiterated its commitment to patient safety.
The drug is designed to provide temporary relief from cough caused by throat and bronchial irritation
The Clinical Trial Application (CTA) approval clears the way for the company to launch trial locations in France and Romania
Originally established in Punjab, the Vasculitis Society of India is now expanding its footprint nationwide
Medical experts point to a growing body of research linking energy drinks to liver injury
The conclave brought together over 1,000 delegates from across India and internationally
Analysts expect modest revenue growth but pressure on profitability in the March quarter
The approved product is a generic version of Ravicti, originally developed and marketed by Horizon Therapeutics
Bajaj joins Health Prime after a long and progressive tenure at Concentrix
The study was conducted by PwC India in line with ISO 14040 and ISO 14044 protocols
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
